Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Factor VIII A.10. Why do patients with ESLD have abnormalities of hemostasis? A.8. Discuss the pathogenesis of preeclampsia. C.6. What are the options to treat acquired hypofibrinogenemia? A.3. What is the treatment for a patient with von Willebrand disease? C.21. What concentrated factors and hemostatic agents are available for bleeding patients?
Famotidine B.6. How should this patient be premedicated? B.10. What preoperative medications, if any, would you give this patient? C.8. What anesthetic agents would you use to induce and maintain general anesthesia in this patient?
Felbamate
Fenoldopam C.10. During the surgery, the blood pressure increases to 220/120 mm Hg. How would you treat the hypertension? C.8. Because this case involves an infrarenal aneurysm, is renal blood flow affected with placement of the cross-clamp? If an endovascular repair is chosen, what are the risks to the kidneys? Are there any treatment maneuvers that can be taken to minimize these risks in either repair? A.14. What is the mechanism of action of the major antihypertensive drugs? C.4. What is the pathophysiology of aortic clamping and unclamping?
Ferrous sulfate
Fibrinogen concentrate C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.9. Two hours later, estimated blood loss (EBL) is approximately 2 L and the patient has been resuscitated with 3 units of packed red blood cells (pRBCs), 229 mL intraoperative cell salvage (cell saver), and 500 mL albumin in addition to 4 L crystalloid. The surgeon says the field is still "oozy" and there is ongoing blood loss. What are your concerns for resuscitation moving forward? How will you guide your resuscitation? C.10. If this patient had a massive blood loss, what blood replacement therapy would be indicated? C.6. What are the options to treat acquired hypofibrinogenemia? D.3. Describe the pathophysiology of potential complications following massive transfusion and hematologic resuscitation. What are the risks of thromboembolic complications after intraoperative administration of procoagulants?
Fletcher D.2. When will you wean the patient from the ventilator? D.3. What are the advantages and disadvantages of early tracheal extubation?
Fludrocortisone
Flumazenil C.3. How does the liver disease affect intraoperative medication management? C.16. What is your approach to emergence? What if the patient does not regain consciousness?
Fluoride C.6. How would you maintain anesthesia during the case? A.5. If succinylcholine were the only NMBA used during the case and the patient did not exhibit a response to TOF stimulation, what is the likely diagnosis? How would you confirm it?
Flurbiprofen
Factor IX
Fentanyl
Fluoxetine
Fluvastatin
Furosemide
Folate